Anti-angiogenic activity of iridoids from Galium tunetanum

被引:30
|
作者
Camero, Cesar Munoz [1 ]
Germano, Maria Paola [2 ]
Rapisarda, Antonio [2 ]
D'Angelo, Valeria [2 ]
Amira, Smain [3 ]
Benchikh, Fatima [3 ]
Braca, Alessandra [1 ]
De Leo, Marinella [1 ]
机构
[1] Univ Pisa, Dipartimento Farm, Pisa, Italy
[2] Univ Messina, Dipartimento Sci Chim Biol Farmaceut & Ambientali, Polo Univ SS, Messina, Italy
[3] Univ Setif, Dept Anim Biol & Physiol, Setif, Algeria
关键词
Anti-angiogenic activity; Asperuloside; Chick chorioallantoic membrane; Geniposidic acid; Iridoid V1; CHEMICAL-CONSTITUENTS; GLUCOSIDES;
D O I
10.1016/j.bjp.2018.03.010
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The phytochemical study of Galium tunetanum Lam., Rubiaceae, leaves led to the isolation of 13 compounds from the chloroform-methanol and the methanol extracts, including six iridoid glycosides, one non-glycoside iridoid, two p-coumaroyl iridoid glycosides, two phenolic acids, and two flavonoid glycosides. The structural determination of the isolated compounds was performed by mono- and bidimensional NMR spectroscopic data, as well as ESI-MS experiments. All compounds were isolated from this species for the first time. The anti-angiogenic effects of the isolated iridoids were also reported on new blood vessels formation using the chick embryo chorioallantoic membrane as in vivo model. Results showed that among the isolated iridoids tested at the dose of 2 mu g/egg, asperuloside (1), geniposidic acid (2), and iridoid V1 (3) reduced microvessel formation of the chorioallantoic membrane on morphological observations using a stereomicroscope. The anti-angiogenic effects of the active compounds, expressed as percentages of inhibition versus control, were 67% (1), 59% (2), and 54% (3), respectively. In addition, the active compounds were able to inhibit angiogenesis in the chorioallantoic membrane assay, in a dose-dependent manner (0.5-2 mu g/egg) as compared to the standard retinoic acid. (C) 2018 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editora Ltda.
引用
收藏
页码:374 / 377
页数:4
相关论文
共 50 条
  • [1] Anti-angiogenic activity of iridoids from Galium tunetanum
    César Muñoz Camero
    Maria Paola Germanò
    Antonio Rapisarda
    Valeria D’Angelo
    Smain Amira
    Fatima Benchikh
    Alessandra Braca
    Marinella De Leo
    Revista Brasileira de Farmacognosia, 2018, 28 : 374 - 377
  • [2] Anti-angiogenic activity of tocotrienol
    Inokuchi, H
    Hirokane, H
    Tsuzuki, T
    Nakagawa, K
    Igarashi, M
    Miyazawa, T
    BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2003, 67 (07) : 1623 - 1627
  • [3] ANTI-ANGIOGENIC ACTIVITY OF SURAMIN
    COLLINS, D
    GAGLIARDI, A
    FASEB JOURNAL, 1992, 6 (05): : A1600 - A1600
  • [4] Anti-angiogenic activity of azathioprine
    Bisneto, Abel Vieira de Melo
    Fernandes, Amanda Silva
    Sa, Vivianne de Souza Velozo
    Veras, Jefferson Hollanda
    Soares, Estefane Thaine Sodre
    Santos, Aline Ferreira da Silva
    Cardoso, Clever Gomes
    Silveira-Lacerda, Elisangela de Paula
    Carneiro, Cristiene Costa
    Chen-Chen, Lee
    MICROVASCULAR RESEARCH, 2021, 138
  • [5] Anti-angiogenic activity of salvicine
    Zhang, Yanli
    Wang, Lei
    Chen, Yajuan
    Qing, Chen
    PHARMACEUTICAL BIOLOGY, 2013, 51 (08) : 1061 - 1065
  • [6] Iridoids from Galium aparine
    Deliorman, D
    Çalis, I
    Ergun, F
    PHARMACEUTICAL BIOLOGY, 2001, 39 (03) : 234 - 235
  • [7] The Anti-angiogenic Activity of Polysaccharides from Chlorella spp
    Tan, Chengyu
    Chen, Yuting
    Hu, Xiaojuan
    Kong, Liang
    Li, Wei
    GLYCOBIOLOGY, 2016, 26 (12) : 1429 - 1429
  • [8] Anti-angiogenic activity of a homoisoflavanone from Cremastra appendiculata
    Shim, JS
    Kim, JH
    Lee, JY
    Kim, SN
    Kwon, HJ
    PLANTA MEDICA, 2004, 70 (02) : 171 - 173
  • [9] ANTI-ANGIOGENIC ACTIVITY OF TRITERPENE ACIDS
    SHON, KH
    LEE, HY
    CHUNG, HY
    YOUNG, HS
    YI, SY
    KIM, KW
    CANCER LETTERS, 1995, 94 (02) : 213 - 218
  • [10] Anti-angiogenic activity of contortrostatin.
    Golubkov, V
    Markland, FS
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (10) : 1207S - 1207S